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Chemical shift imagingAbstract Purpose: To assess the diagnostic effectiveness of unenhanced-multiparametric mag-
netic resonance imaging (mp MRI) as an alternative to gadolinium (Gad)-enhanced MRI in the
characterization of vertebral marrow inﬁltrative lesions.
Patients and methods: A prospective evaluation of ﬁfty-six patients with suspected or untreated
vertebral metastases undergoing MRI of the spine at 1.5 T was carried out. Two groups of
sequences were assigned and compared for the characterization of marrow inﬁltrative lesions: group
[A] unenhanced-mp MRI (including T1-weighted, T2-weighted, short time inversion recovery
(STIR), diffusion weighted imaging (DWI) and in/opposed phase sequences) and group [B]
gadolinium-enhanced MRI (including T1-weighted, T2-weighted, STIR and T1-weighted fat-
suppressed gadolinium-enhanced sequence). Qualitative and quantitative image analysis was
performed and compared. The sensitivity, speciﬁcity, positive predictive value (PPV), negative
predictive value (NPV) and accuracy for both imaging techniques were calculated.
Results: There was no statistical signiﬁcant difference between unenhanced-multiparametric MRI
and gadolinium-enhanced MRI as regards their diagnostic performance in differentiating benign
from malignant vertebral marrow inﬁltrative lesions (p> 0.05) with calculated sensitivity (94%
vs. 97%), speciﬁcity (92% vs. 88%), positive predictive value (94% vs. 91%), negative predictive
value (92% vs. 95%) and (93% vs. 93%) accuracy.
444 D.Z. Zidan, H.A. ElghazalyConclusion: Unenhanced-multiparametric MRI is compatible with gadolinium-enhanced MRI in
reliable characterization of marrow inﬁltrative lesions. The routine MRI protocol of cancer patients
should be altered to accommodate the evolving MRI technology and cost effectively substitute the
need for a gadolinium enhanced scan.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
The vertebral column is the most common site of skeletal
metastasis (1). Radionuclide bone scanning has been repeat-
edly shown to be sensitive but nonspeciﬁc (2). Distinguishing
normal spinal marrow from pathology is essential to avoid
missing pathology or misinterpreting normal changes, either
of which may result in unnecessary additional imaging tests
(3). MRI is the only imaging technique allowing the direct
visualization of bone marrow and is the most sensitive (4).
Although standard MR imaging protocol for bone marrow
with T1-weighted, STIR and T2-weighted techniques is very
sensitive, ﬁndings on images are not speciﬁc (5). Recent devel-
opments in advanced MR techniques and postprocessing soft-
ware have expanded the use of MR imaging to include
quantitative analysis (6).These advances allow for the objective
analysis of composition (7) and architecture down to a molec-
ular level (8,9). New techniques were tried for distinguishing
between malignant and benign bone marrow with varying suc-
cess. These included chemical shift imaging (10,11) and
diffusion-weighted MR imaging allowing for increased conspi-
cuity of lesions (12). In equivocal ﬁndings of bone marrow
lesions gadolinium enhanced study may be done. Although
this increases the length and expense of the MR examination,
it is not clear if it improves diagnosis (13).
Thus, the purpose of this study was to assess the diagnostic
effectiveness of unenhanced multiparametric magnetic reso-
nance imaging (mp MRI) as an alternative to gadolinium-en-
hanced MRI in the characterization of vertebral marrow
inﬁltrative lesions.
2. Patients and methods
2.1. Patients
This prospective study included a total of 56 patients, who
were examined between January 2012 and June 2013, at the
Ain Shams University Hospital MRI Unit. All patients in-
cluded in this study were referred from the clinical oncology
department at the Ain Shams University Hospital with a his-
tory of known primary malignancy and clinically suspected
or untreated vertebral metastases. Patients with multifocal or
diffuse disease pattern were included and patients with solitary
focal vertebral marrow lesion or treated marrow deposits were
excluded from the study group. Other exclusion criteria were
pregnancy, contraindications to MRI (e.g., cardiac pace-
maker) and severe renal insufﬁciency with glomerular ﬁltration
rate <30 ml/min and serum creatinine >2.0 mg/dl.
The study group consisted of 31 male and 25 female pa-
tients, with a mean age of 46 years (age range, 4–83 years).
The known primary tumors of the 56 patients were lymphoma
(n= 18), carcinoma of breast (n= 11), leukemia (10),multiple myeloma (n= 8), carcinoma of prostate (n= 5)
and bronchogenic carcinoma (n= 4).
All patients had provided written consent for the MRI
studies.2.2. MRI technique
MR imaging of the spine of the 56 patients included examina-
tion of the cervical (n= 7), dorsal (n= 18) and lumbosacral
(n= 39) regions, as 2 patients had undergone cervicodorsal
study, 4 patients dorsolumbar study and one patient whole
spine study.
All examinations were performed on a 1.5 MR scanner
(Achieva; Philips Medical Systems, Bothell, WA, USA) using
a spine radio-frequency surface array coil. All Patients had a
history of known primary malignancy, therefore they received
gadolinium as part of the routine protocol of cancer patient at
our MRI unit which consists of the following sequences:
Unenhanced sagittal and axial T1-weighted fast spin-echo
sequence, a sagittal and axial T2-weighted fast spin-echo se-
quence, a sagittal T2-weighted STIR sequence and a contrast-
enhanced sagittal and axial T1-weighted sequence with fat sup-
pression. In this study sagittal diffusion-weighted imaging and
chemical shift (in/opposed phase) sequences were added to the
protocol. The scan parameters were set as follows:
Sagittal T1-weighted turbo spin echo images were acquired
(TR/TE, 424/9; number of slices, 12; slice thickness, 4 mm;
gap, 0.4 mm; ﬂip angle, 80; FOV, 300 mm2). The total imag-
ing time was 1:54 min.
Axial T1-weighted turbo spin echo images were done(TR/
TE, 575/10; number of slices, 25; slice thickness, 5 mm; gap,
0.5 mm; ﬂip angle, 90; FOV, 200 mm2). The total scan dura-
tion was 1:46 min.
Sagittal T2-weighted turbo spin echo images were per-
formed (TR/TE, 2578/100; number of slices, 12; slice thickness,
4 mm; gap, 0.4 mm; ﬂip angle, 90; FOV, 300 mm2). The total
imaging time was 1:51 min.
Axial T2-weighted turbo spin echo images were per-
formed(TR/TE, 3000/100; number of slices, 25; slice thickness,
5 mm; gap, 0.5 mm; ﬂip angle, 90; FOV, 200 mm2). The total
imaging time was 1:06 min.
Sagittal T2-weighted STIR images were acquired (TR/TE,
3761/80; number of slices, 12; slice thickness, 3.8 mm; gap,
1.2 mm; ﬂip angle, 90; FOV, 300 mm2). The total imaging
duration was 2:08 min.
In addition to the routine sequences, sagittal in-phase (TR/
TE, 10/4.6; number of slices, 12; slice thickness, 4 mm; gap,
1 mm; ﬂip angle, 15; FOV, 300 mm2 and the total imaging
duration was 14.1 s) and opposed-phase gradient recalled-echo
sequences (TR/TE, 10/2. 3; number of slices, 12; slice thick-
ness, 4 mm; gap, 1 mm; ﬂip angle, 15; FOV, 300 mm2 and
the total imaging duration was 13.6 s) were acquired.
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recovery single-shot spin-echo echo-planar sequences (TR/
TE, 9000/68; number of slices, 12; slice thickness, 5 mm; gap,
0 mm; ﬂip angle, 90; FOV, 300 mm2).
We applied 3 diffusion-sensitizing gradients with b-values
of 0, 50 and 800 s/mm2. The total imaging time was 6:09 min.
After manual intravenous administration of 0.1 mmol/kg of
gadolinium-DTPA, axial and sagittal T1-weighted fat sup-
pressed sequences with the following parameters were applied:
TR/TE, 574/10; number of slices, 12; slice thickness, 4 mm;
gap, 0 mm; ﬂip angle, 90; FOV, 300 mm2). The total scan
duration was 1:43 min for sagittal images and 2:26 min for ax-
ial scan.
2.3. Image analysis
All images were loaded to a workstation (HPZR 24 W; Philips
Medical Systems). Bone marrow evaluation and image inter-
pretation were performed by two radiologists with expertise
in musculoskeletal MRI working in consensus. During the
MR image analysis, the radiologists were blinded to the clini-
cal history or previous radiologic reports of the study patients.
The images of the applied sequences were divided into two
groups and the radiologists interpreted each group separately.
The ﬁrst group (A) included the unenhanced mp MRI se-
quences (T1-weighted, T2-weighted, STIR, DWI and in/op-
posed phase imaging) and the second group (B) consisted of
gadolinium-enhanced T1-weighted fat-suppressed sequence in
addition to the conventional T1-weighted, T2-weighted and
STIR sequences.
2.3.1. Qualitative analysis
Bone marrow signal intensity was qualitatively analyzed by
visually comparing its signal intensity with the signal intensity
of the non-degenerated intervertebral disc, subcutaneous fat
and muscle tissue depicted on T1-weighted images.
For MRI interpretation, we used previously established
diagnostic criteria for vertebral bone marrow evaluation to in-
clude: Malignant marrow lesions, whether multifocal or dif-
fuse, were deﬁned as those being isointense or hypointense to
muscle or intervertebral disc on T1-weighted images with cor-
responding hyperintensity on T2-weighted or STIR images
(14–16), hyperintense on the DWI with a high b-value (b-va-
lue = 800), lack normal signal dropout on out-of-phase com-
pared with in-phase images (17) and show avid post contrast
enhancement (3).
On the other hand bone marrow lesion with signal intensity
on T1-weighted images higher than disk and muscle, with no
abnormal signal changes on STIR images (18), with a signal
dropout on out-of-phase imaging compared with in-phase
images (17), not hyperintense on high b value DWI and did
not show post contrast enhancement (14) was deﬁned as
benign.
2.3.2. Quantitative analysis
Image post-processing was performed using a workstation (HP
ZR 24 W; Philips Medical Systems). The radiologist quantita-
tively evaluated the bone marrow signal intensity by perform-
ing measurements in regions of interest (ROI). Hyperintense
lesions on the DWI with a high b-value (b 800) which corre-
spond to signal intensity changes on the T1-weighted spin-echoMR images were identiﬁed and the regions of interest were
manually drawn trying to stay within the conﬁnes of the
hyperintensity.
The ROI was lesion-size-dependent in localized discrete le-
sions, but in diffuse vertebral marrow lesions it was drawn as
large as possible placed in the antrocentral aspect of vertebral
body to avoid vertebral end plate degenerative changes and
basivertebral vein plexus. The regions of interest varied be-
tween 5 and 15 mm in diameter. In each patient at least 3
ROI were applied. The ROIs were copied into the computer
memory and pasted onto registered ADC maps.
ADC values were automatically calculated using the soft-
ware provided by the MR scanner manufacturer (Diffusion
Calculation: Philips Medical Systems) and the ADC quantita-
tive parameter was expressed in square millimeters per second
as mean ± SD. The average ADC value of the three regions of
interest of each patient was calculated and recorded.
The ﬁnal diagnosis which was made on the basis of biopsy
results or results of clinical and radiologic follow-up for at
least 6 months, was used as the ‘‘gold standard’’ to classify
the vertebral marrow inﬁltrative lesions as benign or
malignant.
2.4. Statistical analysis
The one-way analysis of variance (ANOVA) test was used for
comparison between 5 independent mean groups for paramet-
ric data to determine the signiﬁcance between the ADC values
of the malignant, normal, inﬂammatory, osteoporotic and red
marrow lesions.
All values were expressed as mean ± SD for quantitative
ADC parametric measures. If the probability of error (p-value)
is less than 0.05, the result was considered statistically signiﬁ-
cant, while at 0.01 and 0.001 was highly and extremely signif-
icant, respectively.
IBM SPSS statistics (V. 21.0, IBM Corp., USA, 2012) and
GraphPad Prism 6 for Windows version 6.03(GraphPad Soft-
ware, San Diego, CA, USA) were used for data analysis. The
diagnostic validity test was done for both unenhanced multi-
parametric magnetic resonance imaging (mp MRI) and gado-
linium-enhanced MRI for vertebral marrow inﬁltrative lesions.
It included the diagnostic sensitivity, speciﬁcity, positive and
negative predictive values and diagnostic accuracy.
3. Results
According to the ‘‘gold standard’’ the ﬁnal results of the 56 pa-
tients included in the study were 24 of benign nature and 32
malignant vertebral marrow inﬁltrative or multifocal lesions.
The 24 patients with benign marrow lesions included 7 patients
with normal marrow, 9 patients with diffuse yellow to red mar-
row reconversion due to anemia or induced by bone marrow –
stimulating factor and bone marrow transplantation, 5 pa-
tients with inﬂammatory/infectious spondylitis or spondylodis-
citis and 3 patients with osteoporosis.
On the other hand the 32 patients with established malig-
nant multifocal or inﬁltrative vertebral marrow lesions in-
cluded lymphomatous and leukemic inﬁltration (n= 9 and
n= 7 respectively), multiple myeloma (n= 5) and metastases
from breast cancer (n= 5), prostate cancer (n= 4), and lung
cancer (n= 2).
446 D.Z. Zidan, H.A. ElghazalyAccording to the criteria of image interpretation previously
mentioned in patients and methods using the two groups of se-
quences (group A) unenhanced-mp MR sequences and (group
B) including the conventional sequences and gad-enhanced T1-
weighted fat suppressed sequence, lesions were classiﬁed as be-
nign and malignant vertebral marrow lesions.
On visual and quantitative assessment of the unenhanced-
mp MRI sequences (group A) 22 of 24 patients with proved
benign lesions were correctly diagnosed and considered trueFig. 1 A 48-year-old female, known case of primary bronchogenic
Unenhanced-mp MRI and gadolinium-enhanced MRI revealed diffuse
echo image shows diffuse low signal intensity of lumbosacral verteb
degenerated intervertebral disc. (b) Sagittal T2-weighted spin-echo ima
DW image at b-value 800 s/mm2 shows diffuse hyperintense signal su
apparent diffusion coefﬁcient (ADC) value of 0.402 · 103 mm2/s. (e
normal signal dropout of vertebral marrow on out-of-phase image com
red marrow reconversion. (g) Sagittal contrast-enhanced T1-weighted
Fig. 2 A 38-year-old man, known case of acute lymphoblastic l
gadolinium-enhanced MRI revealed osteoporosis and negative study
follow up negative MRI study. (a) Sagittal precontrast T1-weighted sp
diffuse heterogenous signal intensity of lumbosacral vertebrae suspici
image at b-value 800 s/mm2 shows signiﬁcantly low marrow signal int
0.142 · 103 mm2/s. (d) In-phase and (e) out-of-phase gradient-echo M
of-phase image compared with in-phase (d). Unenhanced-mp MRI c
enhanced T1-weighted fat-suppressed MR image does not show abnonegative. 8 of the 22 patients with proved benign lesions were
initially false interpreted as malignant lesions according to
imaging criteria on conventional MRI sequences as they exhib-
ited relatively diffuse homogeneous or heterogeneous de-
creased marrow signal intensity on the T1-weighted images
compared with muscle and non-degenerated intervertebral
disc, and increased signal intensity on the T2-weighted and
STIR images .4 of these 8 lesions also showed high signal
intensity on 800 b-value DWI, but their signal dropout oncarcinoma, presented with generalized bony aches and fatigue.
yellow to red marrow reconversion. (a) Sagittal T1-weighted spin-
rae but still higher than adjacent muscle and isointense to non-
ge shows intermediate signal intensity of lumbosacral vertebrae. (c)
ggesting diffuse marrow inﬁltration. (d) ADC map shows average
) In-phase and (f) out-of-phase gradient-echo MR images show
pared with in-phase (h) conﬁrmed the benign nature of yellow to
fat-suppressed MR image shows mild bone marrow enhancement.
eukemia, presented with back pain. Unenhanced-mp MRI and
for bone marrow leukemic inﬁltration conﬁrmed with a 6 month
in-echo image and (b) sagittal T2-weighted spin-echo image show
ous of bone marrow inﬁltration or osteoporotic changes. (c) DW
ensity with average apparent diffusion coefﬁcient (ADC) value of
R images show normal signal dropout of vertebral marrow on out-
onﬁrmed absence of marrow inﬁltration. (f) Sagittal gadolinium-
rmal enhancement.
Diagnostic effectiveness of unenhanced- (mp MRI) as an alternative to (Gad)-enhanced MRI 447opposed phase images conﬁrmed their benign nature of red
marrow reconversion (Fig. 1) which was further conﬁrmed
on follow up study.
2 of these 8 lesions did not exhibit high signal on 800 b-va-
lue DWI and exhibition of a signal dropout on opposed phase
images also conﬁrmed their benignity and osteoporosis was
diagnosed (Fig. 2). On the other hand 2 of the 8 lesions showed
diffusion restriction and no signal dropout on opposed phase
images, but the measured ADC value was high (average
1.4 · 103 mm2/s), benign inﬂammatory/infective nature was
considered and resolution of abnormal signal intensity on fol-
low up MRI conﬁrmed their benign nature (Fig. 3). 2 of 24 be-
nign lesions were false positive as they met the malignant
imaging criteria on all unenhanced-mp MRI included se-
quences, but histopathological veriﬁcation and follow upFig. 3 A 34-year-old man with known bronchogenic carcinoma p
gadolinium-enhanced MRI revealed L3/l4 spondylodiscitis with preve
spin-echo image shows diffuse low signal intensity of L3 and L4 verteb
Sagittal T2-weighted spin-echo image and sagittal STIR (c) show corr
DWimage at b-value 800 s/mm2 shows diffusion restriction of L3 and
epidural component. (e) ADC map shows a high apparent diffusion c
inﬂammatory/infectious nature of the lesion. (f) in-phase and (g) out
signal on out-of-phase image compared with in-phase (f). (h) Sagittal
corresponding avid enhancement.MRI revealed extensive hypercellular hematopoietic marrow
after bone marrow transplantation.
Gad-enhanced MRI (group B) correctly diagnosed 21 of 24
proved benign lesions as they did not show postcontrast
enhancement apart from three false positive benign lesions that
exhibited appreciable contrast enhancement, two of which
were diffuse red marrow and the third lesion was spondylitis.
Follow up studies with stationary course of the enhancing
red marrow and resolution of abnormal signal intensity in
spondylitis conﬁrmed their benign nature.
Of the 32 cases with proved malignant lesions, 31 had de-
creased signal intensity compared with muscle on the T1-
weighted images. On the T2-weighted and STIR sequences 5
lesions were isointense to normal marrow; the remaining 26 le-
sions were hyperintense and metastatic disease was conﬁrmedresented with back pain and fever. Unenhanced-mp MRI and
rtebral and epidural abscess. (a) Sagittal precontrast T1-weighted
rae associated with prevertebral and epidural soft tissue mass. (b)
esponding high signal intensity and bright signal of L3/4 disc. (d)
L4 vertebrae and intervening disc as well as the prevertebral and
oefﬁcient (ADC) value of 1.452 · 103 mm2/s, which conﬁrms the
-of-phase gradient-echo MR images show corresponding brighter
contrast-enhanced T1-weighted fat-suppressed MR image shows
448 D.Z. Zidan, H.A. Elghazalyon gad-enhanced fat-suppressed T1sequence in 31 out of 32
patients. One false-negative study with no appreciable signal
alteration or contrast enhancement on group B sequences
was encountered, but leukemic inﬁltration was later seen on
one month follow up MRI study and conﬁrmed with biopsy
results.Fig. 4 A 58-year-old man with known lymphoma of the spleen pr
gadolinium-enhanced MRI revealed diffuse marrow inﬁltration. (a) Sa
signal intensity of lumbosacral vertebrae isointense to muscle and in
Sagittal T2-weighted spin-echo image shows diffuse slightly high signa
with heterogenous signal of L1 vertebral body. (c) Sagittal STIR show
DWimage at b-value 800 s/mm2 shows diffuse hyperintense signal of
diffusion coefﬁcient (ADC) value of 0.523 · 103 mm2/s. (f) In-phas
marrow appears slightly brighter on out-of-phase image compared w
suppressed MR image shows diffuse bone marrow avid enhancement.On the other hand unenhanced-mp MRI sequences (group
A) qualitatively and quantitatively correctly diagnosed 30 out
of 32 patients with proved malignant lesions. They exhibited
marked diffusion restriction on b-value 800 DWI, ADC mean
value 0.623 · 103 mm2/s ± 0.121 · 103 mm2 SD and did not
show signal dropout on opposed phase sequences (Figs. 4 andesented with generalized bony aches. Unenhanced-mp MRI and
gittal precontrast T1-weighted spin-echo image shows diffuse low
tervertebral discs, consistent with bone marrow involvement. (b)
l intensity of lumbosacral vertebrae and mild compression collapse
s mild diffuse high signal intensity of lumbosacral vertebrae. (d)
lumbosacral vertebrae. (e) ADC map shows an average apparent
e and (g) out-of-phase gradient-echo MR images show vertebral
ith in-phase (f). (h) Sagittal contrast-enhanced T1-weighted fat-
Diagnostic effectiveness of unenhanced- (mp MRI) as an alternative to (Gad)-enhanced MRI 4495). 2 out of 32 patients with malignant lesions were false neg-
ative, one had diffuse tiny lymphomatous inﬁltrates on top of
hematopoietic marrow and the other patient had initial normal
study, but the vertebral marrow inﬁltrations in both patientsFig. 5 A 75-year-old man with known prostate cancer received ta
generalized bony aches and bilateral sciatica. Unenhanced-mp MRI and
deposits. (a) Sagittal precontrast T1-weighted spin-echo image and (
intensity marrow deposits involving D12, L2, L3 and L4 vertebrae as
collapse of L1 with retropulsion and thecal sac compression is noted. L
radiation therapy targeting the prostate. (c) Sagittal STIR shows mild h
800 s/mm2 shows focal and diffuse hyperintense signal corresponding
average apparent diffusion coefﬁcient (ADC) value of 0.624 · 103 m
show vertebral marrow lesions appear brighter on out-of-phase imag
vertebrae remain hyperintense on both in- and out-of-phase images. N
vertebral end plates have similar signal intensity as subcutaneous fat
contrast-enhanced T1-weighted fat-suppressed MR image shows a milwere later obvious on the 1 month follow up MRI and histo-
pathological veriﬁcation conﬁrmed the diagnosis.
The ADC values recorded from the automatically
created ADC maps differed signiﬁcantly (p< 0.001) betweenrgeted radiotherapy for the prostate. The patient presented with
gadolinium-enhanced MRI revealed focal and inﬁltrative marrow
b) Sagittal T2-weighted spin-echo image shows focal low signal
well as diffuse inﬁltration of D11 and L1 vertebrae. Compression
5 and sacral vertebral bodies show fat marrow replacement due to
igh signal intensity of the marrow lesions. (d) DW image at b-value
to the low signal intensity lesions on T1WI. (e) ADC map shows
m2/s. (f) in-phase and (g) out-of-phase gradient-echo MR images
e compared with in-phase (f). The fatty inﬁltrated L5 and sacral
ote that Modic type 2 degenerative marrow changes at L2 and L3
and do not dropout on out-of-phase imaging (arrow). (h) Sagittal
d enhancement of the focal and inﬁltrative marrow lesions.
Table 1 Mean apparent diffusion coefﬁcient values for normal, benign and malignant marrow lesions.
ADC value at b-800 Benign marrow lesion Malignant marrow lesion Normal marrow
Mean ADC values ± S.D* Osteoporosis (0.189 ± 0.029) 0.506 ± 0.101 0.278 ± 0.083
Red marrow (0.575 ± 0.212)
Inﬂammatory/infective (1.641 ± 0.322)
* Data are mean (·103 mm2/s) ± standard deviation, ADC= apparent diffusion coefﬁcient.
450 D.Z. Zidan, H.A. Elghazalymalignant (mean, 0.623 · 103 mm2/s; SD ± 0.121 · 103 -
mm2/s) and the following benign marrow entities, namely nor-
mal marrow (mean, 0.278 · 103 mm2/s; SD± 0.083 ·
103 mm2/s), osteoporosis (mean, 0.189 · 103 mm2/s; SD ±
0.029 · 103 mm2/s and infective /inﬂammatory marrow le-
sions (mean, 1.641 ± 0.322 · 103 mm2/s; SD ± 0.322 ·
103 mm2/s). On the other hand the ADC values of malignant
lesions and benign red marrow (mean, 0.575 · 103 mm2/s;
SD ± 0.212 · 103 mm2/s) did not differ signiﬁcantly with
p value >0.05 (Table 1 and Fig. 6).Fig. 6 Box plot showing differences in apparent diffusion
coefﬁcient (ADC) between normal, malignant, inﬂammation/
infection, red marrow and osteoporosis. The line within the box
marks median value.
Table 3 Scan duration of unenhanced-multiparametric MRI study
group (B).
Study group Group (A)
Unenhanced mp MRI
Scan duration in minutes Conventional 8:4
DWI 6:0
IN/OUT phase 0:2
Total scan duration in minutes 15:
Table 2 The results of group (A) unenhanced-multiparametric MR
MRI studies.
Total no
of cases
TP TN FP FN Sen
Group (A) unenhanced mp MRI 56 30 22 2 2 94
Group (B) conventional and
Gad-enhanced MRI
56 31 21 3 1 97
TP true positive, TN true negative, FP false positive, FN false negative.Based on the above mentioned results of qualitative, quan-
titative image analysis and gold standard, the sensitivity, spec-
iﬁcity, PPV, NPV and accuracy for differentiating benign from
malignant vertebral marrow lesions on unenhanced-mp MRI
and gadolinium-enhanced images added to conventional
MRI are shown in Table 2. The sensitivity, speciﬁcity, and
accuracy of unenhanced-mp MR images were 94%, 92%,
and 93% and the T1-weighted fat-suppressed contrast-en-
hanced images added to conventional MRI were 97%, 88%,
and 93%. There was no statistically signiﬁcant difference be-
tween unenhanced-mp MRI and gadolinium-enhanced MRI
(p value > 0.05) as regards their diagnostic performance in dif-
ferentiating benign from malignant vertebral marrow inﬁltra-
tive lesions.
We also calculated the scan duration of group (A) and
group (B) included sequences (shown in Table 3) which was
15 min 22 s and 13 min 24 s respectively.4. Discussion
In recent years, MRI has increasingly become the modality of
choice for imaging musculoskeletal disorders (19–21). MRI is
very sensitive to detect bone marrow metastases, although
improving speciﬁcity needs a good understanding of normal
and abnormal marrow appearance and a clever use of acquisi-
tion sequences and contrast media (22). The red marrow is
more cellular and more perfused than the yellow marrow
and contains only 40% fat compared to 80% fat in yellowof group (A) and conventional/gadolinium-enhanced study of
Group (B)
Conventional and Gad-enhanced MRI
5 Conventional 8:45
9 T1WI post contrast axial and sagittal 4:09
8 Time for contrast injection 0:30
22 13:24
I and group (B) conventional and gadolinium (Gad)-enhanced
sitivity (%) Speciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
92 94 92 93
88 91 95 93
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the MRI interpretation is the difﬁculty in differentiating dif-
fuse marrow inﬁltrative lesions from the highly variable
appearance of normal hypercellular hematopoietic red mar-
row. The hypercellular red marrow may appear homoge-
neously diffuse, simulating a marrow-inﬁltrative tumor, or
focal and patchy, simulating metastases (25). Skeletal muscles
adjacent to bone or non-degenerated intervertebral disk are
accurate internal standards and can serve as simple tools to
help in differentiating normal and abnormal bone marrow
on T1-weighted spin-echo MRI (18). In this study T1-weighted
MRI accurately depicted and characterized the malignant mul-
tifocal metastatic deposits as well as focal and diffuse red mar-
row that exhibited signal intensity higher than adjacent muscle,
but in 4 patients with profound red marrow reconversion and 4
patients with advanced osteoporosis (Fig. 2) or extensive bone
marrow edema (Fig. 3), it was difﬁcult to differentiate from
malignancy based on T1-weighted image alone. Grifﬁth et al.
(26) reported that on T1-weighted images, osteoporosis can
have a heterogeneous appearance because of decreased cellular
marrow components and increased fat content. Also, hemato-
poietic marrow hyperplasia, diffuse inﬂammatory/infective
marrow edema and diffuse malignant marrow inﬁltration
showed diffuse high signal intensity on STIR sequence. Stan-
dard conventional MRI sequences were not speciﬁc for the
characterization of inﬁltrative marrow lesions as 8 out of 56
cases were misinterpreted. This was in agreement with Beltran
et al. (5) and Zhao et al. (18) who conﬁrmed the non speciﬁcity
of conventional imaging techniques.
Schmid et al. (27) concluded that addition of T1-weighted
contrast-enhanced MR imaging does not alter the diagnosis
of bone marrow abnormalities, and for most cases, they rec-
ommend performing only the STIR sequence. This was contra-
dictory to our study supported by previous results of
Rahmouni et al. (28), which revealed that the addition of gad-
olinium-enhanced T1 weighted sequence improved lesion con-
spicuity and characterization of our cases, although we agree
with Daldrup-Link et al. (29), who reported that gadolinium-
enhancement of the markedly hypercellular marrow and inﬁl-
trated marrow in patients with hematologic malignancies
shows considerable overlap and is of limited clinical value
for a deﬁnitive differentiation of these entities. This was in
compliance with two false positive patients who had apprecia-
ble post-gadolinium bone marrow enhancement due to pro-
found hypercellular hematopoietic red marrow. On the other
hand one patient with early leukemic inﬁltrates was false neg-
ative on gadolinium-enhanced study, this was in agreement
with Vande Berg et al. (16) who found normal bone marrow
appearance and enhancement in early diffuse invasion by
hematological malignancies. Mosher (13) reported that in clin-
ical practice when faced with diagnostic uncertainty in the
evaluation of abnormal marrow ﬁndings, indiscriminant use
of contrast-enhanced images simply serves to conﬁrm the obvi-
ous, with little diagnostic effectiveness. On the other hand the
risks associated with administration of intravenous gadolinium
based contrast medium, most notably, nephrogenic systemic
ﬁbrosis (30–32) can occur in patients with severe renal impair-
ment, although it is rare in patients with normal renal function
(33). Therefore, in this study, patients with severe renal impair-
ment were excluded. Accordingly, we applied the two newly
developed noncontrast-based DWI and opposed phase chemi-
cal shift MR techniques.DWI should be considered a powerful functional technique
for musculoskeletal imaging. The option of contrast-free scan-
ning certainly is of clinical signiﬁcance (34,35). The principle
underlying DWI is based on the measurement of the restric-
tions on the Brownian motion of water molecules (36). Water
movement is relatively impeded in tightly packed tumoral cells
and high cellularity tissues appear persistently bright on low
and high b-value DWI (37).
In this study we found that visual assessment of high signal
intensity on high b-value (800) was not speciﬁc for malignancy
because inﬂammation and hyperactive hematopoietic marrow
can result in a similar diffusion restriction (Figs. 1 and 3),this
was in agreement with Koh et al. (38) and Ballon et al. (39). On
the other hand the quantitative assessment by measuring the
ADC value was able to distinguish benign from malignant
high signal intensity on DWI (Figs. 3 and 5).This was in agree-
ment with Padhani et al. (14), who highlighted the necessity of
correlating high b-value DW images with corresponding ADC
values to prevent misinterpretation due to T2 shine-through.
Our observations supported by other studies (14,40–43)
showed that normal yellow marrow had the lowest ADC value
and the inﬁltrated neoplastic marrow as well as hypercellular
red marrow had higher ADC value, on the other hand the
infective/inﬂammatory bone marrow lesion had the highest
ADC value (Table 1 and Fig. 6). Thus, it was concluded that
signal intensity and ADC value difference between yellow mar-
row and malignant marrow were not overlapping, but the sig-
nal intensity difference between malignant and inﬂammatory/
infective lesion was overlapping although the ADC value dif-
ference between the two entities was statistically signiﬁcant
with p value <0.001. On the other hand, in agreement with
Padhani et al. (14), there was narrow signal intensity and
ADC value difference between malignant and red marrow.
In this study the narrow signal intensity difference hindered
the depiction of minor marrow inﬁltration on top of hyperac-
tive red marrow in 2 patients.
In this study the diagnostic problem of narrow signal inten-
sity difference between hypercellular red marrow and malig-
nant inﬁltration was almost solved by the addition of in/out-
of-phase chemical shift sequence to the unenhanced-mp MRI
protocol. Chemical shift imaging takes advantage of the small
differences in precession frequency between fat and water pro-
tons to determine the presence of microscopic fat and water
within the same imaging voxel. If a given voxel contains both
fat and water, drop of signal on out-of-phase images will be
noted (44).
On the other hand, lesions composed of virtually 100% fat
will not show a drop of signal on out-of-phase sequence (11),
this was in concordance with our ﬁndings where hemangioma,
fat island, Modic type 2 vertebral endplate marrow changes
and radiotherapy induced profound fatty marrow did not ex-
hibit signal dropout (Fig. 5).
Red marrow shows normal signal dropout on out-of-phase
images because of the presence of both fat and water cells, on
the other hand most neoplasms completely replace or displace
fat in the marrow space; thus, the neoplastic area will lack nor-
mal signal dropout on out-of-phase images (45–47) and this
was consistent with our ﬁndings (Figs. 1 and 4) .
Roberts et al. (1) suggested out-of-phase sequence to best
assess for marrow replacement by tumor. In this study 7 out
of 9 cases with hypercellular red marrow showed a drop in sig-
nal intensity on out-of-phase images (Fig. 1), but no drop in
452 D.Z. Zidan, H.A. Elghazalysignal intensity was noted in malignant marrow lesions (Figs. 4
and 5), these results were concordant with Moulopoulos et al.
(48). However, 2 of 9 cases with hypercellular red marrow did
not exhibit visually obvious signal dropout on opposed phase
images, this was likely attributed to extremely hypercellular
marrow after bone marrow transplantation, that vigorously re-
placed the fat cells.
In this unenhanced-mp MRI (group A) study the addition
of chemical shift sequence improved the MRI diagnostic per-
formance in discriminating between benign and malignant
marrow lesions.
Our results showed that the sensitivity, speciﬁcity and accu-
racy for unenhanced-mp MRI (group A) were 94%, 92%, and
93% respectively, which were almost comparable to those cal-
culated for gadolinium-enhanced MRI (group B), where sensi-
tivity of 97%, speciﬁcity of 88% and accuracy of 93% were
reported. While the overall diagnostic performance of gadolin-
ium-enhanced MRI and unenhanced-mp MRI may be similar,
the latter has the advantage of not using intravenous contrast
media.
The scan duration of unenhanced-mp MRI (group A) was
2 min longer than gadolinium-enhanced (group B) study.
To our knowledge, the diagnostic value of unenhanced-mp
MRI in comparison with gadolinium-enhanced imaging in the
evaluation of marrow inﬁltrative lesions has not been reported.
Further investigation is recommended to establish the unen-
hanced mp MRI as a reliable alternative technique to contrast
based MRI in clinical practice and its impact on monitoring
treatment response, however this latter issue was beyond the
scope of this study.
In conclusion, according to the results of this study, unen-
hanced-multiparametric MRI is compatible with gadolinium-
enhanced MRI in reliable characterization of marrow inﬁltra-
tive lesions. The routine MRI protocol of cancer patients
should be altered to accommodate the evolving MRI technol-
ogy and cost effectively substitute the need for gadolinium en-
hanced scan.
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